Corden Pharma International

Aeschenvorstadt 71
4051 Basel
Switzerland

Contact WebSite

Article

CordenPharma Expands Peptide Manufacturing Platform in Switzerland
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

CordenPharma Invests €900 Million in Peptide Platform Expansion
16.07.2024 • News

CordenPharma Invests €900 Million in Peptide Platform Expansion

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.